骨关节炎中的siRNA疗法:针对细胞通路进行先进的治疗方法
Yunshen Li1,2,3, Jianan Zhao1,2,3, Shicheng Guo1
1Department of Rheumatology, Shanghai Guanghua Hospital of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Frontiers in immunology
|June 19, 2024
概括
小干扰RNA (siRNA) 疗法通过沉默参与软骨退化和炎症的特定基因,对骨关节炎 (OA) 显示出前景. 这篇评论探讨了siRNA.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 类风湿病学 类风湿病学
背景情况:
- 骨关节炎 (OA) 是一种普遍的关节疾病,以软骨退化和炎症为特征,影响全球数百万人.
- 骨关节炎的发病过程涉及体细胞,突细胞,骨质母细胞和免疫细胞的复杂相互作用,导致组织损伤和疼痛.
研究的目的:
- 审查使用小干扰RNA (siRNA) 治疗骨关节炎的RNA干扰 (RNAi) 疗法的机制.
- 探索siRNA在调节关键细胞路径中的潜力,这些路径与OA病原发生有关.
- 总结siRNA传递系统的进展和OA管理的治疗目标.
主要方法:
- 文献综述侧重于OA中的siRNA机制.
- 分析siRNA在向细胞过程中的作用,如增殖,亡,衰老,自,炎症和骨重塑.
- 评估目前的siRNA输送系统和潜在的治疗点.
主要成果:
- siRNA疗法为OA提供了特定的基因沉默能力.
- siRNA可以调节涉及OA细胞功能障碍的关键通路.
- 交付系统的进步对于临床翻译至关重要.
结论:
- 基于siRNA的策略对骨关节炎具有显著的治疗潜力.
- 对传递系统和目标的进一步研究对于开发有效的OA治疗是必不可少的.
- 本综述为基于siRNA的新型OA诊断和治疗方法提供了基础.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


